Our discovery and development teams are working to find a biomarker driven therapy for a functional cure of chronic hepatitis B.

We employ engineered bionanoparticles (BNPs) of hepatitis B surface antigen (HBsAg) delivering clearance epitope target inserts.

CLB-3000-01-001 clinical trial information can be found by clicking the button below.

CLB-4000-1-001 clinical trial information can be found by clicking these buttons below.